Mandeep R. Mehra, MD
Dr. Mehra is the first incumbent of the William Harvey Distinguished Chair in Advanced Cardiovascular Medicine, a Professor of Medicine at Harvard Medical School and served as the founding Medical Director of the Heart and Vascular Center and is the Executive Director of the Center for Advanced Heart Disease at Brigham and women’s Hospital in Boston, Massachusetts. Additionally, he is Editor-in-Chief, The Journal of Heart and Lung Transplantation, the #1 ranked journal in its field. Dr. Mehra is a Past-President (2008) of the International Society of Heart and Lung Transplantation (ISHLT) and immediate past president of the Heart Failure Society of America (HFSA).
He has authored and published over 500 scholarly papers with a specific focus on Advanced HeartFailure related to discovery of the obesity paradox, describing the natural history of cardiac allograft vasculopathy, establishing pivotal international guidelines for the care of transplant patients, defining the role of new immunosuppression as well asgenomic based biomarkers for evaluating cardiac allograft rejection. In recent years his research focus shifted to evaluation of novel left ventricular assist devices engineered to reduce the burden of adverse effects and allow use in broader populations of patients. This work published in the New England Journal of Medicine has resulted in the introduction of novel therapy for advanced heart failure patients.
Dr. Mehra has a certificate in Executive leadership from the Harvard Business School and also completed a Master of Science in Health Economics and Management at the London School of Economics in 2018, a degree earned through his designation as a “Braunwald Scholar”.
While members of the Medical Advisory Board are consulted to provide third party expert medical input into Triple-Gene’s product development efforts and clinical trial activities, they do not dictate or direct, nor are they responsible for, any development or clinical activities ultimately undertaken by Triple-Gene.